Eric C. Leuthardt

Eric C. Leuthardt, MD

Specializes In
  • Neurosurgery
  • Brain Tumors
  • Pituitary Tumors
Gender

Male

Languages Spoken
  • English

Appointments

Sees Patients For

Brain Laser Center, neuro-oncology, spine surgery, brain tumors, brain tumors requiring motor and speech mapping, surgical treatment of epilepsy, Monteris laser ablation and Gamma Knife

Hospital Affiliations

  • Barnes-Jewish Hospital
  • St. Louis Children's Hospital

Locations

Experience

Board Certifications

  • Neurological Surgery

Academic Title(s)

Professor, Neurological Surgery, Neuroscience, Biomedical Engineering, and Mechanical Engineering and Materials Science
Director, Center for Innovation in Neuroscience and TechnologyDirector, Brain Laser Center

Research Interests

Neuroprosthetics – devices linked to the brain that may lead to cures for paralysis, allow patients to move artificial limbs or restore other neurological functions. Brain Mapping – developing advanced techniques to locate and preserve critical areas of brain function.

Publications & Research

Search PubMed for publications »

Education

Fellowship

2006 Spine and Epilepsy, Department of Neurosurgery, University of Washington School of Medicine and Harborview Medical Center, Seattle, Washington

Chief Residency

2005 Neurological Surgery, Barnes-Jewish Hospital & Washington University School of Medicine, St Louis, Missouri

Residency

2005 Neurological Surgery, Barnes-Jewish Hospital & Washington University School of Medicine, St. Louis, Missouri

Medical Degree

1999 University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

B.S.

1995 Biology and Theology, Saint Louis University, St. Louis, Missouri.

Financial Disclosures
  • ACERA
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • Alcyone
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2021
  • Caeli Vascular
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • Immunovalent
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • inner Cosmos
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • Neuroloutions, Inc.
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • Osteovantage, Inc.
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • Pear Therapeutics, Inc.
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • Sora Imaging Solutions
    • Equity: Yes
    • Reporting Date: 05/01/2021
  • SympEL Neuromodulation
    • Equity: Yes
    • Reporting Date: 05/01/2021

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.